Concepedia

Floor Hageman

FH

Statistics

Publications

3

Citations

166

H-Index

3

Active since

2015

Affiliations

University of Amsterdam(Current)

Amsterdam UMC Location University of Amsterdam

The Netherlands Cancer Institute

AstraZeneca (United Kingdom)

Oncode Institute

Floor Hageman is an author at University of Amsterdam specializing in radiation oncology, tumor biology, and radiation therapy.

Top concepts

Publications per year

2015–2018

3

Publications

3

Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells

Caroline V.M. Verhagen, Rosemarie de Haan, Floor Hageman et al. · Radiotherapy and Oncology · 2015 · 111 citations

, , +10

Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity

Amy J.C. Dohmen, Xiaohang Qiao, Anja Duursma et al. · Oncotarget · 2017 · 30 citations · Full text

Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects <i>in vitro</i> and poor outcome in patients with advanced head and neck squamous cell carcinoma

Caroline V.M. Verhagen, David M. Vossen, Kerstin Borgmann et al. · Oncotarget · 2018 · 25 citations · Full text

1–3 of 3